Page last updated: 2024-09-04

matteucinol and temozolomide

matteucinol has been researched along with temozolomide in 1 studies

*Temozolomide: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA. [MeSH]

Compound Research Comparison

Studies (matteucinol)	Trials (matteucinol)	Recent Studies (post-2010) (matteucinol)	Studies (temozolomide)	Trials (temozolomide)	Recent Studies (post-2010) (temozolomide)
9	0	4	6,014	826	4,331

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chagas, RCR; Gonçalves, AS; Melo, ESA; Netto, JB; Oliveira, AGS; Reis, RM; Ribeiro, RIMA; Santiago, LR; Santos, DM; Santos, HB; Sousa, LR; Thomé, RG	1

Other Studies

1 other study(ies) available for matteucinol and temozolomide

Article	Year
Matteucinol combined with temozolomide inhibits glioblastoma proliferation, invasion, and progression: an in vitro, in silico, and in vivo study. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2022, Volume: 55 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chromones; Computational Biology; Glioblastoma; Humans; Receptors, Tumor Necrosis Factor, Type I; Temozolomide	2022

Article

Year

Matteucinol combined with temozolomide inhibits glioblastoma proliferation, invasion, and progression: an in vitro, in silico, and in vivo study.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2022, Volume: 55

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chromones; Computational Biology; Glioblastoma; Humans; Receptors, Tumor Necrosis Factor, Type I; Temozolomide

2022